Platinum-resistant Peritoneal Cancer
specificPrimary peritoneal carcinoma that progresses between one and six months of completing platinum therapy.
4
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Platinum-resistant Peritoneal Cancer(4)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 62.5 |
| 2 | University of Illinois Cancer CenterChicago, IL | 62.5 |
| 3 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 62.5 |
| 4 | Princess Margaret Cancer CentreToronto, ON | 62.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →